Synthesis of a Sulfonimidamide-Based Analog of Tasisulam and Its Biological Evaluation in the Melanoma Cell Lines SKMel23 and A375.

about

Sulfonimidamides in Medicinal and Agricultural Chemistry.A New, Practical One-Pot Synthesis of Unprotected Sulfonimidamides by Transfer of Electrophilic NH to Sulfinamides.Exploration of Novel Chemical Space: Synthesis and in vitro Evaluation of N-Functionalized Tertiary Sulfonimidamides.

P2860

Q39037342-61B86A49-0E4B-4455-B4E0-5181C6F57143 Q45767567-715B9397-326F-436B-8ADA-EA0A3549280F Q52803327-FAE36864-762B-46C5-B726-70ACF73EE284

P2860

Synthesis of a Sulfonimidamide-Based Analog of Tasisulam and Its Biological Evaluation in the Melanoma Cell Lines SKMel23 and A375.

Item

http://www.wikidata.org/entity/Q38724420

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Synthesis of a Sulfonimidamide ...... a Cell Lines SKMel23 and A375.

@en

type

Item

label

Synthesis of a Sulfonimidamide ...... a Cell Lines SKMel23 and A375.

@en

prefLabel

Synthesis of a Sulfonimidamide ...... a Cell Lines SKMel23 and A375.

@en

P1476

Synthesis of a Sulfonimidamide ...... a Cell Lines SKMel23 and A375.

@en

P2093

Jens M Baron

http://www.w3.org/2001/XMLSchema#string

Katharina Fietkau

http://www.w3.org/2001/XMLSchema#string

Laurenz Schmitt

http://www.w3.org/2001/XMLSchema#string

Ruth Heise

http://www.w3.org/2001/XMLSchema#string

Xiaoyun Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

The lab oddity prevails: discovery of pan-CDK inhibitor (R)-S-cyclopropyl-S-(4-{[4-{[(1R,2R)-2-hydroxy-1-methylpropyl]oxy}-5-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)sulfoximide (BAY 1000394) for the treatment of cancer

Nivolumab plus ipilimumab in advanced melanoma.

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

Cancer statistics, 2010

Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study

Nivolumab and ipilimumab versus ipilimumab in untreated melanoma

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group.

Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma.

P304

281-290

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000453042

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Carsten Bolm

Anne-Dorothee Steinkamp

P577

2016-12-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28013301

http://www.w3.org/2001/XMLSchema#string

Synthesis of a Sulfonimidamide-Based Analog of Tasisulam and Its Biological Evaluation in the Melanoma Cell Lines SKMel23 and A375.

about

P2860

P2860

Synthesis of a Sulfonimidamide-Based Analog of Tasisulam and Its Biological Evaluation in the Melanoma Cell Lines SKMel23 and A375.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698